AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2010

Oct 19, 2010

29745_dirs_2010-10-19_e7973020-e527-481e-839b-7a5298346547.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-10-15

Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-15	Common Stock	S	3100	$37.65	Disposed	66440	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5997	Indirect

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010.